Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

Clinical trial NCT00754052 · TERMINATED

Trial details

NCT number: NCT00754052
Sponsor: Eisai Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Down Syndrome Cognitive Dysfunction

Start date: 2008-09-01
Primary completion: 2008-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.